Ligand validation:4ALU

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ALU_IMD_A_1307	81%	80%	0.12	0.974	0.47	0.38	-	-	1	0	100%	1
4ALW_IMD_A_1307	99%	56%	0.059	0.988	0.32	1.34	-	-	1	0	100%	1
4A7C_IMD_A_1307	98%	75%	0.055	0.981	0.4	0.56	-	-	0	0	100%	1
1YXU_IMD_C_700	94%	78%	0.068	0.968	0.35	0.54	-	-	0	0	100%	1
3R00_IMD_A_1001	90%	76%	0.087	0.969	0.37	0.58	-	-	0	0	100%	1
5TEX_IMD_A_401	83%	68%	0.114	0.973	0.72	0.51	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.